The increased secretion of IL33 in tumor-associated fibroblasts has been reported to enhance the immunosuppressive function of ILC2s, Tregs and myeloid cells and promote the growth of pancreatic cancer [48]. Here, IL33 is linked to pancreatic neoplasm.